NDC Directory Finished Products
Table of FINISHED Products
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | RxNorm | Status | |
|---|---|---|---|---|---|---|---|---|
| 50242-007 | Enspryng | Satralizumab | Injection, Solution | Subcutaneous | Genentech, Inc. | ACTIVE | ||
| 50242-014 | Tnkase | Tenecteplase | Kit | Genentech, Inc. | ACTIVE | |||
| 50242-040 | Xolair | Omalizumab | Injection, Solution | Subcutaneous | Genentech, Inc. | ACTIVE | ||
| 50242-041 | Cathflo Activase | Alteplase | Injection, Powder, Lyophilized, For Solution | Intravenous | Genentech, Inc. | ACTIVE | ||
| 50242-044 | Activase | Alteplase | Kit | Genentech, Inc. | ACTIVE | |||
| 50242-051 | Rituxan | Rituximab | Injection, Solution | Intravenous | Genentech, Inc. | ACTIVE | ||
| 50242-053 | Rituxan | Rituximab | Injection, Solution | Intravenous | Genentech, Inc. | ACTIVE | ||
| 50242-060 | Avastin | Bevacizumab | Injection, Solution | Intravenous | Genentech, Inc. | ACTIVE | ||
| 50242-061 | Avastin | Bevacizumab | Injection, Solution | Intravenous | Genentech, Inc. | ACTIVE | ||
| 50242-070 | Gazyva | Obinutuzumab | Injection, Solution, Concentrate | Intravenous | Genentech, Inc. | ACTIVE | ||
| 50242-077 | Herceptin Hylecta | Trastuzumab And Hyaluronidase-oysk | Injection, Solution | Subcutaneous | Genentech, Inc. | ACTIVE | ||
| 50242-078 | Susvimo | Ranibizumab | Injection, Solution | Intravitreal | Genentech, Inc. | ACTIVE | ||
| 50242-079 | Itovebi | Inavolisib | Tablet, Film Coated | Oral | Genentech, Inc. | ACTIVE | ||
| 50242-080 | Lucentis | Ranibizumab | Injection, Solution | Intravitreal | Genentech, Inc. | ACTIVE | ||
| 50242-082 | Lucentis | Ranibizumab | Injection, Solution | Intravitreal | Genentech, Inc. | ACTIVE | ||
| 50242-084 | Itovebi | Inavolisib | Tablet, Film Coated | Oral | Genentech, Inc. | ACTIVE | ||
| 50242-085 | Activase | Alteplase | Kit | Genentech, Inc. | ACTIVE | |||
| 50242-087 | Kadcyla | Ado-trastuzumab Emtansine | Injection, Powder, Lyophilized, For Solution | Intravenous | Genentech, Inc. | ACTIVE | ||
| 50242-088 | Kadcyla | Ado-trastuzumab Emtansine | Injection, Powder, Lyophilized, For Solution | Intravenous | Genentech, Inc. | ACTIVE | ||
| 50242-090 | Zelboraf | Vemurafenib | Tablet, Film Coated | Oral | Genentech, Inc. | ACTIVE | ||
| 50242-091 | Rozlytrek | Entrectinib | Capsule | Oral | Genentech, Inc. | ACTIVE | ||
| 50242-094 | Rozlytrek | Entrectinib | Capsule | Oral | Genentech, Inc. | ACTIVE | ||
| 50242-096 | Vabysmo | Faricimab | Injection, Solution | Intravitreal | Genentech, Inc. | ACTIVE | ||
| 50242-100 | Pulmozyme | Dornase Alfa | Solution | Respiratory (inhalation) | Genentech, Inc. | ACTIVE | ||
| 50242-103 | Polivy | Polatuzumab Vedotin | Injection, Powder, Lyophilized, For Solution | Intravenous | Genentech, Inc. | ACTIVE | ||
| 50242-105 | Polivy | Polatuzumab Vedotin | Injection, Powder, Lyophilized, For Solution | Intravenous | Genentech, Inc. | ACTIVE | ||
| 50242-108 | Rituxan Hycela | Rituximab And Hyaluronidase | Injection, Solution | Subcutaneous | Genentech, Inc. | ACTIVE | ||
| 50242-109 | Rituxan Hycela | Rituximab And Hyaluronidase | Injection, Solution | Subcutaneous | Genentech, Inc. | ACTIVE | ||
| 50242-115 | Piasky | Crovalimab | Injection, Solution | Subcutaneous | Genentech, Inc. | ACTIVE | ||
| 50242-120 | Tnkase | Tenecteplase | Kit | Genentech, Inc. | ACTIVE | |||
| 50242-122 | Esbriet | Pirfenidone | Tablet, Coated | Oral | Genentech, Inc. | ACTIVE | ||
| 50242-123 | Esbriet | Pirfenidone | Tablet, Coated | Oral | Genentech, Inc. | ACTIVE | ||
| 50242-125 | Columvi | Glofitamab | Solution, Concentrate | Intravenous | Genentech, Inc. | ACTIVE | ||
| 50242-127 | Columvi | Glofitamab | Concentrate | Intravenous | Genentech, Inc. | ACTIVE | ||
| 50242-130 | Alecensa | Alectinib Hydrochloride | Capsule | Oral | Genentech, Inc. | ACTIVE | ||
| 50242-132 | Herceptin | Trastuzumab | Injection, Powder, Lyophilized, For Solution | Intravenous | Genentech, Inc. | ACTIVE | ||
| 50242-135 | Actemra | Tocilizumab | Injection, Solution, Concentrate | Intravenous | Genentech, Inc. | ACTIVE | ||
| 50242-136 | Actemra | Tocilizumab | Injection, Solution, Concentrate | Intravenous | Genentech, Inc. | ACTIVE | ||
| 50242-137 | Actemra | Tocilizumab | Injection, Solution, Concentrate | Intravenous | Genentech, Inc. | ACTIVE | ||
| 50242-138 | Actemra | Tocilizumab | Injection, Solution | Subcutaneous | Genentech, Inc. | ACTIVE | ||
| 50242-140 | Erivedge | Vismodegib | Capsule | Oral | Genentech, Inc. | ACTIVE | ||
| 50242-142 | Lunsumio | Mosunetuzumab | Concentrate | Intravenous | Genentech, Inc. | ACTIVE | ||
| 50242-143 | Actemra Actpen | Tocilizumab | Injection, Solution | Subcutaneous | Genentech, Inc. | ACTIVE | ||
| 50242-145 | Perjeta | Pertuzumab | Injection, Solution, Concentrate | Intravenous | Genentech, Inc. | ACTIVE | ||
| 50242-150 | Ocrevus | Ocrelizumab | Injection | Intravenous | Genentech, Inc. | ACTIVE | ||
| 50242-159 | Lunsumio | Mosunetuzumab | Concentrate | Intravenous | Genentech, Inc. | ACTIVE | ||
| 50242-175 | Evrysdi | Risdiplam | Powder, For Solution | Oral | Genentech, Inc. | ACTIVE | ||
| 50242-176 | Tnkase | Tenecteplase | Kit | Genentech, Inc. | ACTIVE | |||
| 50242-177 | Lunsumio Velo | Mosunetuzumab | Injection | Subcutaneous | Genentech, Inc. | ACTIVE | ||
| 50242-201 | Lunsumio Velo | Mosunetuzumab | Injection | Subcutaneous | Genentech, Inc. | ACTIVE | ||
| 50242-202 | Evrysdi | Risdiplam | Tablet | Oral | Genentech, Inc. | ACTIVE | ||
| 50242-210 | Gavreto | Pralsetinib | Capsule | Oral | Genentech, Inc. | ACTIVE | ||
| 50242-214 | Xolair Pfs | Omalizumab | Injection, Solution | Subcutaneous | Genentech, Inc. | ACTIVE | ||
| 50242-215 | Xolair Pfs | Omalizumab | Injection, Solution | Subcutaneous | Genentech, Inc. | ACTIVE | ||
| 50242-227 | Xolair | Omalizumab | Injection, Solution | Subcutaneous | Genentech, Inc. | ACTIVE | ||
| 50242-245 | Phesgo | Pertuzumab, Trastuzumab, And Hyaluronidase-zzxf | Injection, Solution | Subcutaneous | Genentech, Inc. | ACTIVE | ||
| 50242-260 | Phesgo | Pertuzumab, Trastuzumab, And Hyaluronidase-zzxf | Injection, Solution | Subcutaneous | Genentech, Inc. | ACTIVE | ||
| 50242-554 | Ocrevus Zunovo | Ocrelizumab And Hyaluronidase | Injection, Solution | Subcutaneous | Genentech, Inc. | ACTIVE | ||
| 50242-583 | Xofluza | Baloxavir Marboxil | Granule, For Solution | Oral | Genentech, Inc. | ACTIVE | ||
| 50242-599 | Xofluza | Baloxavir Marboxil | Granule, For Suspension | Oral | Genentech, Inc. | ACTIVE | ||
| 50242-617 | Xofluza | Baloxavir Marboxil | Granule, For Suspension | Oral | Genentech, Inc. | ACTIVE | ||
| 50242-623 | Rozlytrek | Entrectinib | Pellet | Oral | Genentech, Inc. | ACTIVE | ||
| 50242-717 | Cotellic | Cobimetinib | Tablet, Film Coated | Oral | Genentech, Inc. | ACTIVE | ||
| 50242-860 | Xofluza | Baloxavir Marboxil | Tablet, Film Coated | Oral | Genentech, Inc. | ACTIVE | ||
| 50242-877 | Xofluza | Baloxavir Marboxil | Tablet, Film Coated | Oral | Genentech, Inc. | ACTIVE | ||
| 50242-917 | Tecentriq | Atezolizumab | Injection, Solution | Intravenous | Genentech, Inc. | ACTIVE | ||
| 50242-918 | Tecentriq | Atezolizumab | Injection, Solution | Intravenous | Genentech, Inc. | ACTIVE | ||
| 50242-920 | Hemlibra | Emicizumab | Injection, Solution | Subcutaneous | Genentech, Inc. | ACTIVE | ||
| 50242-921 | Hemlibra | Emicizumab | Injection, Solution | Subcutaneous | Genentech, Inc. | ACTIVE | ||
| 50242-922 | Hemlibra | Emicizumab | Injection, Solution | Subcutaneous | Genentech, Inc. | ACTIVE | ||
| 50242-923 | Hemlibra | Emicizumab | Injection, Solution | Subcutaneous | Genentech, Inc. | ACTIVE | ||
| 50242-927 | Hemlibra | Emicizumab | Injection, Solution | Subcutaneous | Genentech, Inc. | ACTIVE | ||
| 50242-930 | Hemlibra | Emicizumab | Injection, Solution | Subcutaneous | Genentech, Inc. | ACTIVE | ||
| 50242-933 | Tecentriq Hybreza | Atezolizumab And Hyaluronidase-tqjs | Injection | Subcutaneous | Genentech, Inc. | ACTIVE | ||
| 50254-693 | Slap Happy | Slap Happy | Liquid | Topical | Beaver Research Company | ACTIVE | ||
| 50261-104 | Imvexxy | Estradiol | Insert | Vaginal | Mayne Pharma Llc | ACTIVE | ||
| 50261-110 | Imvexxy | Estradiol | Insert | Vaginal | Mayne Pharma Llc | ACTIVE | ||
| 50261-211 | Bijuva | Estradiol And Progesterone | Capsule | Oral | Mayne Pharma Llc | ACTIVE | ||
| 50261-251 | Bijuva | Estradiol And Progesterone | Capsule | Oral | Mayne Pharma Llc | ACTIVE | ||
| 50268-032 | Abiraterone Acetate | Abiraterone Acetate | Tablet | Oral | Avpak | ACTIVE | ||
| 50268-033 | Alprazolam | Alprazolam | Tablet | Oral | Avpak | ACTIVE | ||
| 50268-034 | Alprazolam | Alprazolam | Tablet | Oral | Avpak | ACTIVE | ||
| 50268-035 | Alprazolam | Alprazolam | Tablet | Oral | Avpak | ACTIVE | ||
| 50268-036 | Amantadine | Amantadine | Solution | Oral | Avpak | ACTIVE | ||
| 50268-037 | Amitriptyline Hydrochloride | Amitriptyline Hydrochloride | Tablet, Film Coated | Oral | Avpak | ACTIVE | ||
| 50268-038 | Amitriptyline Hydrochloride | Amitriptyline Hydrochloride | Tablet, Film Coated | Oral | Avpak | ACTIVE | ||
| 50268-039 | Amitriptyline Hydrochloride | Amitriptyline Hydrochloride | Tablet, Film Coated | Oral | Avpak | ACTIVE | ||
| 50268-040 | Amitriptyline Hydrochloride | Amitriptyline Hydrochloride | Tablet, Film Coated | Oral | Avpak | ACTIVE | ||
| 50268-041 | Amitriptyline Hydrochloride | Amitriptyline Hydrochloride | Tablet, Film Coated | Oral | Avpak | ACTIVE | ||
| 50268-042 | Acetazolamide Extended-release | Acetazolamide Extended-release | Capsule | Oral | Avpak | ACTIVE | ||
| 50268-043 | Artificial Tears | Artificial Tears | Solution/ Drops | Ophthalmic | Avpak | ACTIVE | ||
| 50268-044 | Clotrimazole | Clotrimazole | Solution | Topical | Avpak | ACTIVE | ||
| 50268-049 | Abacavir | Abacavir | Tablet | Oral | Avpak | ACTIVE | ||
| 50268-050 | Acebutolol Hydrochloride | Acebutolol Hydrochloride | Capsule | Oral | Avpak | ACTIVE | ||
| 50268-054 | Acetazolamide | Acetazolamide | Tablet | Oral | Avpak | ACTIVE | ||
| 50268-057 | Atomoxetine Hydrochloride | Atomoxetine Hydrochloride | Capsule | Oral | Avpak | ACTIVE | ||
| 50268-058 | Atomoxetine Hydrochloride | Atomoxetine Hydrochloride | Capsule | Oral | Avpak | ACTIVE | ||
| 50268-059 | Atomoxetine Hydrochloride | Atomoxetine Hydrochloride | Capsule | Oral | Avpak | ACTIVE | ||
| 50268-061 | Acyclovir | Acyclovir | Tablet | Oral | Avpak | ACTIVE | ||
| 50268-062 | Acyclovir | Acyclovir | Tablet | Oral | Avpak | ACTIVE |
TOTAL FINISHED PRODUCTS: 114,585
TOTAL FINISHED PRODUCTS BY TYPE
HUMAN PRESCRIPTION DRUG PRODUCTS: 55,907
HUMAN OTC DRUG PRODUCTS: 55,873
NON-STANDARDIZED ALLERGENIC PRODUCTS: 2,197
PLASMA DERIVATIVE PRODUCTS: 318
VACCINE PRODUCTS: 143
STANDARDIZED ALLERGENIC PRODUCTS: 125
CELLULAR THERAPY PRODUCTS: 22